MeSH term
Frequency | Condition_Probility | Animals | 56 | 0.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
Humans | 140 | 0.0 |
Orthomyxoviridae/*genetics | 3 | 42.0 |
Adult | 15 | 0.0 |
Child | 4 | 0.0 |
Male | 20 | 0.0 |
*Mutation | 9 | 0.0 |
Random Amplified Polymorphic DNA Technique | 2 | 8.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 59 | 0.0 |
Time Factors | 4 | 0.0 |
Comparative Study | 24 | 0.0 |
Rats | 7 | 0.0 |
Sensitivity and Specificity | 6 | 0.0 |
Adolescent | 5 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Female | 27 | 0.0 |
Middle Aged | 11 | 0.0 |
Protein C/*analysis/metabolism | 2 | 66.0 |
Reagent Kits, Diagnostic/*standards | 2 | 8.0 |
Reproducibility of Results | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 79 | 0.0 |
Thromboembolism/blood | 2 | 25.0 |
Thrombophilia/blood/diagnosis | 3 | 60.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Blood Coagulation Tests/standards | 2 | 66.0 |
Child, Preschool | 3 | 0.0 |
Infant | 2 | 0.0 |
Pregnancy | 4 | 0.0 |
ROC Curve | 2 | 1.0 |
Retrospective Studies | 2 | 0.0 |
*Genes, Plant | 2 | 20.0 |
Molecular Sequence Data | 37 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 16 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 9 | 0.0 |
RNA, Viral/genetics | 2 | 2.0 |
Reference Values | 2 | 0.0 |
Protein C/*genetics | 21 | 46.0 |
Alleles | 3 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Family Health | 2 | 0.0 |
Heterozygote | 4 | 0.0 |
*Mutation, Missense | 3 | 0.0 |
Protein S/*genetics | 4 | 23.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Exons/genetics | 3 | 0.0 |
Genotype | 3 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Mutation, Missense/genetics | 2 | 1.0 |
Nucleic Acid Denaturation | 2 | 2.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Mice | 17 | 0.0 |
Point Mutation | 2 | 0.0 |
*Escherichia coli Proteins | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Models, Biological | 3 | 0.0 |
Phosphorylation | 3 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Conformation | 6 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Base Sequence | 31 | 0.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
Conserved Sequence | 3 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Genes, Reporter | 2 | 0.0 |
*Introns | 2 | 0.0 |
Liver Neoplasms | 2 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Transfection | 6 | 0.0 |
Exons | 5 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Protein C Deficiency/*genetics | 3 | 30.0 |
Homozygote | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Blood Coagulation Disorders/*diagnosis | 2 | 25.0 |
Mutation | 10 | 0.0 |
*Partial Thromboplastin Time | 2 | 11.0 |
Reagent Kits, Diagnostic | 2 | 1.0 |
Emigration and Immigration | 3 | 6.0 |
*Models, Biological | 2 | 1.0 |
Hamsters | 5 | 0.0 |
*Models, Statistical | 2 | 3.0 |
Binding Sites | 4 | 0.0 |
Chickens | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Amino Acid Sequence | 22 | 0.0 |
DNA Primers | 4 | 0.0 |
Escherichia coli/genetics | 2 | 0.0 |
Introns | 3 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Software | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
Cell Line | 15 | 0.0 |
DNA, Recombinant | 2 | 1.0 |
Plasmids | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Hela Cells | 3 | 0.0 |
Neutralization Tests | 3 | 0.0 |
Variation (Genetics) | 4 | 0.0 |
Biological Transport, Active | 2 | 1.0 |
In Vitro | 2 | 0.0 |
Oxidation-Reduction | 3 | 0.0 |
DNA Probes | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Protein C/genetics | 3 | 20.0 |
Cattle | 4 | 0.0 |
Chromosome Mapping | 9 | 0.0 |
Genome, Human | 2 | 0.0 |
*Nerve Tissue Proteins | 2 | 0.0 |
*Transcription Factors | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Protein C/*genetics/metabolism | 3 | 33.0 |
Pedigree | 9 | 0.0 |
Cells, Cultured | 7 | 0.0 |
Phenotype | 3 | 0.0 |
Prevalence | 2 | 0.0 |
Crystallization | 2 | 0.0 |
Hydrogen-Ion Concentration | 3 | 0.0 |
*Protein Structure, Secondary | 2 | 1.0 |
Thermodynamics | 2 | 0.0 |
*Protein C Deficiency | 5 | 10.0 |
Precipitin Tests | 2 | 0.0 |
Sequence Analysis | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Introns/genetics | 2 | 0.0 |
Sequence Alignment | 4 | 0.0 |
DNA/biosynthesis | 2 | 0.0 |
Recombinant Fusion Proteins/immunology | 2 | 1.0 |
Osmolar Concentration | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
*Bacterial Adhesion | 3 | 6.0 |
Molecular Weight | 11 | 0.0 |
Rabbits | 5 | 0.0 |
Haplotypes | 2 | 0.0 |
*Models, Genetic | 3 | 2.0 |
DNA/*genetics | 4 | 1.0 |
*Homozygote | 2 | 1.0 |
Protein C Deficiency | 4 | 11.0 |
*Variation (Genetics) | 2 | 0.0 |
Cross Reactions | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
*Chromosomes, Human, Pair 16 | 2 | 0.0 |
Hybrid Cells | 3 | 0.0 |
Evolution | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Neurons/*physiology | 2 | 1.0 |
Thrombophlebitis/*genetics | 4 | 25.0 |
*Genes, Structural | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Culture Media | 6 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Microscopy, Electron | 7 | 0.0 |
Centrifugation, Density Gradient | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Mathematics | 4 | 2.0 |
*Multigene Family | 3 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Species Specificity | 6 | 0.0 |
Virus Replication | 2 | 0.0 |
Glutathione Transferase/*genetics | 2 | 0.0 |
Restriction Mapping | 6 | 0.0 |
*Genome, Human | 2 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Recurrence | 4 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
DNA/genetics | 5 | 0.0 |
Gene Expression | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
DNA | 2 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Substrate Specificity | 3 | 0.0 |
*Genes | 2 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Staining and Labeling | 2 | 0.0 |
Proteins/*isolation & purification | 2 | 40.0 |
*Cell Adhesion | 2 | 1.0 |
*Extracellular Matrix Proteins | 2 | 1.0 |
Chemistry | 2 | 0.0 |
Antigen-Antibody Complex | 2 | 1.0 |
Carcinoma, Squamous Cell | 2 | 1.0 |
Immune Sera | 2 | 0.0 |
Chromatography, Affinity/methods | 2 | 2.0 |
Guinea Pigs | 2 | 0.0 |
